Doctors & Their Families Less Likely to Follow Medical Guidelines Than Others
TUESDAY, Dec. 20, 2022 (HealthDay News) — Doctors are notorious for criticizing patients who don’t take medications as prescribed.But physicians and their families are themselves less likely than everyone else to comply with medication guidelines, a …
Learn MoreFDA Approves Gene Therapy for Tough-to-Treat Bladder Cancer
MONDAY, Dec. 19, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved a gene therapy called Adstiladrin (nadofaragene firadenovec-vncg), which is designed to work for patients with high-risk non-muscle-invasive bladder can…
Learn MoreMetformin Use Linked to Lower Risk for Joint Replacement in T2DM
MONDAY, Dec. 19, 2022 (HealthDay News) — For patients with type 2 diabetes, metformin use is associated with a reduced risk for total knee replacement (TKR) and total hip replacement (THR), according to a study published online Dec. 19 in CMAJ, the j…
Learn MoreASH: Glofitamab Aids Relapsed, Refractory Diffuse Large B-Cell Lymphoma
MONDAY, Dec. 19, 2022 (HealthDay News) — The bispecific antibody that recruits T cells to tumor cells, glofitamab, is effective for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), according to a study published online Dec….
Learn MoreSublingual Buprenorphine/Naloxone Tied to More Adverse Dental Outcomes
FRIDAY, Dec. 16, 2022 (HealthDay News) — There is a higher risk for adverse dental outcomes associated with sublingual buprenorphine/naloxone compared with transdermal buprenorphine or oral naltrexone, according to a research letter published in the …
Learn MoreRocatinlimab Effective for Moderate-to-Severe Atopic Dermatitis
THURSDAY, Dec. 15, 2022 (HealthDay News) — The anti-OX40 antibody rocatinlimab is effective for adults with confirmed atopic dermatitis with moderate-to-severe disease activity, according to a study published online Dec. 9 in The Lancet.Emma Guttman-…
Learn More¿Qué provoca la escasez actual de Adderall, y qué pueden hacer los padres?
MARTES, 13 de diciembre de 2022 (HealthDay News) — Se prevé que la escasez de Adderall, el medicamento para el trastorno de déficit de atención e hiperactividad (TDAH), continúe durante meses, lo que obliga a las familias a esforzarse para encontrar …
Learn MoreDrop in Mortality Seen With AChEI, Memantine in Dementia With Lewy Bodies
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — For patients with dementia with Lewy bodies (DLB), treatment with acetylcholinesterase inhibitors (AChEIs) and/or memantine is associated with reduced hospital admissions and mortality, according to a study…
Learn MoreSABCS: Interrupting Endocrine Therapy Does Not Pose Breast Cancer Recurrence Risk
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — For young women with early-stage hormone receptor (HR)-positive breast cancer (BC) desiring pregnancy, temporary interruption of endocrine therapy does not confer a greater short-term risk for recurrence th…
Learn MoreUSPSTF Recommends PrEP for Reducing Risk for HIV Acquisition
TUESDAY, Dec. 13, 2022 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) recommends preexposure prophylaxis (PrEP) for reducing the risk for HIV infection among individuals at increased risk for HIV acquisition. This recommendation …
Learn More